Compare TECX & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECX | RYAM |
|---|---|---|
| Founded | 2019 | 1926 |
| Country | United States | United States |
| Employees | N/A | 2325 |
| Industry | | Paper |
| Sector | | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.9M | 580.4M |
| IPO Year | 2018 | 2014 |
| Metric | TECX | RYAM |
|---|---|---|
| Price | $23.33 | $6.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $76.63 | N/A |
| AVG Volume (30 Days) | 233.3K | ★ 821.8K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,466,397,000.00 |
| Revenue This Year | N/A | $0.86 |
| Revenue Next Year | N/A | $7.38 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.45 | $5.38 |
| 52 Week High | $39.53 | $11.85 |
| Indicator | TECX | RYAM |
|---|---|---|
| Relative Strength Index (RSI) | 33.51 | 30.71 |
| Support Level | $20.52 | N/A |
| Resistance Level | $30.80 | $8.81 |
| Average True Range (ATR) | 1.39 | 0.37 |
| MACD | 0.11 | -0.15 |
| Stochastic Oscillator | 27.11 | 14.43 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.